Mauldin, I. S., Slingluff, C. L., & Wang, E. (2014). TLR2/6 agonists and IFN-gamma treatment induces favorable immune cell recruiting signatures from melanoma associated with STAT1 and IL-32 signaling. J Immunother Cancer.
Stile di citazione ChicagoMauldin, Ileana S., Craig L. Slingluff, e Ena Wang. "TLR2/6 Agonists and IFN-gamma Treatment Induces Favorable Immune Cell Recruiting Signatures From Melanoma Associated With STAT1 and IL-32 Signaling." J Immunother Cancer 2014.
Citazione MLAMauldin, Ileana S., Craig L. Slingluff, e Ena Wang. "TLR2/6 Agonists and IFN-gamma Treatment Induces Favorable Immune Cell Recruiting Signatures From Melanoma Associated With STAT1 and IL-32 Signaling." J Immunother Cancer 2014.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.